138 results on '"Petera, Jiri"'
Search Results
2. Cancer Diseases
3. High-dose-rate brachytherapy at 3 Gy per fraction for lip carcinoma: Treatment outcomes and toxicity at 5-years
4. Prognostic Factors for Survival in Glioblastoma: A Retrospective Analysis Focused on the Role of Hemoglobin.
5. How public health services pay for radiotherapy in Europe: an ESTRO–HERO analysis of reimbursement
6. Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
7. Validation of dose distribution computation on sCT images generated from MRI scans by Philips MRCAT
8. Cardiac doses with deep inspiration breath hold in breast cancer radiotherapy: direct comparison between WBI, PBI, and interstitial APBI.
9. Accelerated partial breast irradiation with perioperative multicatheter interstitial brachytherapy—A feasibility study
10. Diagnostic Utility of Immunohistochemical Detection of MEOX2, SOX11, INSM1 and EGFR in Gliomas
11. Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer
12. High-dose-rate brachytherapy in early oral cancer with close or positive margins
13. Guidelines for equipment and staffing of radiotherapy facilities in the European countries: Final results of the ESTRO-HERO survey
14. Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000–2008
15. The dynamics of telomere length in primary and metastatic colorectal cancer lesions.
16. Palliative care among elderly cancer patients: Own experience
17. Management of Onsite and Remote Communication in Oncology Hospitals: Data Protection in an Era of Rapid Technological Advances.
18. Utilization of cone-beam CT for offline evaluation of target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignment
19. Non-closure of peritoneum after abdominal hysterectomy for uterine carcinoma does not increase late intestinal radiation morbidity
20. Total body irradiation for standard treatment rooms: a robust sweeping beam technique with respect to the body shape
21. 804: Postoperative HDR BRT alone in T1-3N0M0 oral cancer with negative progn. factors:retrospective study
22. High–dose rate brachytherapy in the treatment of penile carcinoma—First experience
23. Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer
24. Prognostic Significance of Human Papillomavirus (HPV) Status and Expression of Selected Markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on Outcome After (Chemo-) Radiotherapy in Patients with Squamous Cell Carcinoma of Uterine Cervix
25. Preoperative neoadjuvant chemoradiation for locally advanced gastric adenocarcinoma
26. IMRT using simultaneous integrated boost (66 Gy in 6 weeks) with and without concurrent chemotherapy in head and neck cancer – toxicity evaluation
27. Overview of radiation oncology in the Czech Republic
28. Epidermal Growth Factor Receptor as a Predictor of Tumor Response to Preoperative Chemoradiation in Locally Advanced Gastric Carcinoma
29. Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients
30. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: A prospective randomised study
31. Prognostic Impact of Hemoglobin Level Prior to Radiotherapy on Survival in Patients with Glioblastoma
32. Distant Metastasis in Colorectal Cancer Patients—Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review
33. How public health services pay for radiotherapy in Europe: an ESTRO–HERO analysis of reimbursement
34. Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer
35. Tamoxifen and arrhythmia
36. Quality of life and depression among metastatic breast cancer patients
37. Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer
38. Comparison of rectal dose-volume constraints for IMRT prostate treatment planning
39. Solitary Extramedullary Plasmacytoma in the Oropharynx: Advantages of Intensity-Modulated Radiation Therapy
40. Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer
41. Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
42. Guidelines for equipment and staffing of radiotherapy facilities in the European countries: Final results of the ESTRO-HERO survey
43. Prognostic Significance of Human Papillomavirus (HPV) Status and Expression of Selected Markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on Outcome After (Chemo-) Radiotherapy in Patients with Squamous Cell Carcinoma of Uterine Cervix
44. Utilization of cone-beam CT for reconstruction of dose distribution delivered in image-guided radiotherapy of prostate carcinoma - bony landmark setup compared to fiducial markers setup
45. P-0016 Brachytherapy of Inoperable Oesophageal Carcinoma
46. P-0211 The Prognostic Significance of Tumor Egfr Expression After Neoadjuvant Chemoradiation in Patients With Rectal Adenocarcinoma
47. Hypersensitivity to chemoradiation in FANCA carrier with cervical carcinoma—A case report and review of the literature
48. Tamoxifen and arrhythmia
49. Quality of life and depression among metastatic breast cancer patients
50. HematideTM, a Synthetic Peptide-Based Erythropoiesis Stimulating Agent (ESA), Assessed for Correction of Anemia in Oncology Patients Receiving Chemotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.